US2022133816A1PendingUtilityA1

Feed additive formulation and methods of making and using the same

Assignee: BIORESOURCE INT INCPriority: Mar 7, 2017Filed: Jan 20, 2022Published: May 5, 2022
Est. expiryMar 7, 2037(~10.6 yrs left)· nominal 20-yr term from priority
A61K 47/02A23K 50/30A61K 2035/115C12Y 302/01008A61P 33/02A23K 10/18A61P 1/14A23K 20/189A23K 50/75A61K 9/0056A61K 35/742A61P 31/04A23K 20/24A61K 38/47C12N 1/20
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The presently disclosed subject matter relates to feed additive formulations for monogastric animal feed. Particularly, the disclosed formulations comprise an isolated xylanase enzyme and a B. licheniformis strain PWD-1. The feed additive formulations may further include B. amyloliquefaciens strain Ba-BPD1. The disclosed formulations are useful for addition to feeds for monogastric animals to synergistically improve the performance of the animals.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A feed additive formulation for monogastric animal feed, the formulation comprising an isolated xylanase enzyme and a biologically pure culture of a  Bacillus licheniformis  strain PWD-1 (Accession No. 53757), or a mutant thereof having all the identifying characteristics thereof. 
     
     
         2 . The feed additive formulation of  claim 1 , further comprising a biologically pure culture of a  Bacillus amyloliquefaciens  strain Ba-BPD1 (Accession No. DSM 21836), or a mutant thereof having all the identifying characteristics thereof. 
     
     
         3 . The feed additive formulation of  claim 1 , wherein the xylanase is an endo-1,4-beta-xylanase. 
     
     
         4 . The feed additive formulation of  claim 1 , wherein the formulation is a solid, a powder, a suspension concentrate, a liquid, or a granule. 
     
     
         5 . The feed additive formulation of  claim 1 , further comprising a carrier. 
     
     
         6 . The feed additive formulation of  claim 5 , wherein the carrier comprises limestone. 
     
     
         7 . The feed additive formulation of  claim 1 , wherein the xylanase ranges from 10,000-200,000 units/gram and the  Bacillus licheniformis  ranges from 10 8 -10 12  CFU/gram. 
     
     
         8 . The feed additive formulation of  claim 2 , wherein the xylanase ranges from 10,000-200,000 units/gram, the  Bacillus licheniformis  ranges from 10 8 -10 12  CFU/gram, and the  Bacillus amyloliquefaciens  ranges from 10 8 -10 12  CFU/gram. 
     
     
         9 . A feed composition for monogastric animals comprising the feed additive formulation of  claim 1 . 
     
     
         10 . The feed composition of  claim 9 , further comprising a biologically pure culture of a  Bacillus amyloliquefaciens  strain Ba-BPD1 (Accession No. DSM 21836), or a mutant thereof having all the identifying characteristics thereof. 
     
     
         11 . The feed composition of  claim 9 , wherein the xylanase ranges from 5-30 units/gram feed and the  Bacillus licheniformis  ranges from at least 5×10 4  CFU/gram feed. 
     
     
         12 . The feed composition of  claim 10 , wherein the xylanase ranges from 5-30 units/gram feed and each of the  Bacillus licheniformis  and the  Bacillus amyloliquefaciens  ranges from at least 10 5  CFU/gram feed for a total of at least 1×10 5  CFU/gram feed. 
     
     
         13 . A method for increasing the performance of a monogastric animal comprising:
 administering to the monogastric animal an effective amount of a feed composition comprising a xylanase enzyme and a biologically pure culture of a  Bacillus licheniformis  strain PWD-1 (Accession No. 53757), or a mutant thereof having all the identifying characteristics thereof.   
     
     
         14 . The method of  claim 13 , wherein the feed composition further comprises a biologically pure culture of a  Bacillus amyloliquefaciens  strain Ba-BPD1 (Accession No. DSM 21836), or a mutant thereof having all the identifying characteristics thereof. 
     
     
         15 . The method of  claim 13 , wherein the xylanase is an endo-1,4-beta-xylanase. 
     
     
         16 . The method of  claim 13 , wherein the animal is poultry. 
     
     
         17 . The method of  claim 16 , wherein the animal is a broiler. 
     
     
         18 . The method of  claim 13 , wherein the animal is swine. 
     
     
         19 . The method of  claim 13 , wherein the increase in performance comprises one or a combination of: increased average daily weight gain, increased total weight gain, improved feed conversion rate, reduced lesion score, reduced mortality, reduced disease, or decreased pathogen incidence. 
     
     
         20 . The method of  claim 19 , wherein one or both of the disease and lesion score is a result of one or a combination of  Clostridium perfringens, Eimeria acervulina, Eimeria maxima, Eimeria tenella  or Coccidiosis-inducing parasites. 
     
     
         21 . The method of  claim 19 , wherein the animal is poultry and the increase in performance comprises reduced lesion score resulting from one or a combination of  Clostridium perfringens  or  Eimeria  spc. 
     
     
         22 . The method of  claim 19 , wherein the animal is poultry and the decreased pathogen incidence is a decreased  Salmonella  incidence. 
     
     
         23 . A method of preparing a feed composition for monogastric animals, comprising adding to the feed composition a formulation comprising a xylanase enzyme and a biologically pure culture of a  Bacillus licheniformis  strain PWD-1 (Accession No. 53757), or a mutant thereof having all the identifying characteristics thereof. 
     
     
         24 . The method of  claim 23 , wherein the formulation further comprises a biologically pure culture of a  Bacillus amyloliquefaciens  strain Ba-BPD1 (Accession No. DSM 21836), or a mutant thereof having all the identifying characteristics thereof. 
     
     
         25 . The method of  claim 23 , wherein the xylanase is an endo-1,4-beta-xylanase. 
     
     
         26 . The method of  claim 23 , wherein the formulation is a solid, a powder, a suspension concentrate, a liquid, or a granule. 
     
     
         27 . The method of  claim 23 , wherein the xylanase ranges from 5-30 units/gram feed and the  Bacillus licheniformis  ranges from at least 5×10 4  CFU/gram feed. 
     
     
         28 . The method of  claim 24 , wherein the xylanase ranges from 5-30 units/gram feed and each of the  Bacillus licheniformis  and the  Bacillus amyloliquefaciens  ranges from at least 10 5  CFU/gram feed for a total of at least 1×10 5  CFU/gram feed.

Join the waitlist — get patent alerts

Track US2022133816A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.